These are three low-income countries with HIV prevalence rates of roughly 15%. Further assuming a relatively generous 20% administration overhead, the total cost of the scheme would be approximately $600 million – equivalent to a fifth of the reported aid flow to these countries in 2004 and to 3.5-4% of their combined GDP.